UW Health recruiting volunteers for clinical trial of new Alzheimer’s drug
UW Health is recruiting volunteers for a clinical trial to test a new Alzheimer's drug recently approved by the FDA....
07 July, 2023
Author: UW CTI
Alzheimer’s drug Leqembi gets full FDA approval. Medicare coverage will likely follow
The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease....
06 July, 2023
Carbone Cancer Center named one of America’s Best Cancer Hospitals
Newsweek's inaugural list of America’s Best Cancer Hospitals 2023, ranks UW Health | Carbone Cancer Center the top cancer hospital in Wisconsin and 30th in the United States....
28 June, 2023
FDA issues first draft guidance on clinical trials with psychedelic drugs
The U.S. Food and Drug Administration published a new draft guidance to highlight fundamental considerations to researchers investigating the use of psychedelic drugs for potential treatment of medical conditions, including psychiatric or substance use disorders....
23 June, 2023
What role should artificial intelligence play in nursing?
Ann Wieben, a UW Clinical Trials Institute colleague, discusses her research on the use of machine learning/artificial intelligence in nursing. Ann is a clinical research program specialist at UW Health and a Ph.D. candidate in the UW–Madison School of Nursing....
21 June, 2023
UW clinical trial for severe dry mouth treatment launching soon
The UW Health | Carbone Cancer Center and UW Program for Advanced Cell Therapy, or PACT, will soon begin a clinical trial using a recently developed cell therapy to treat severe dry mouth....
16 June, 2023
Precision oncology focuses on treating patients’ individual cancer needs
New initiatives at UW Health seek to highlight and streamline patient access to individualized, data-driven cancer care....
15 June, 2023
Industry-sponsored Clinical Trials Budget Template to launch July 1
The UW Clinical Trials Institute (CTI) will implement a budget template in support of a consistent clinical trials budgeting experience for industry sponsors across SMPH and UW Health....
09 June, 2023
FDA approves MDMA for clinical trial use investigating schizophrenia
Investigators will be assessing the use of the drug to treat impaired social motivation, or asociality, which is a symptom of schizophrenia that can cause significant functional impairment....
09 June, 2023
Progress on Alzheimer’s Disease
According to UW–Madison geriatrician Nathaniel Chin, "We are on a trajectory for prevention."...
09 June, 2023